Blocking knee blood vessels may offer new pain relief for severe osteoarthritis

NCT ID NCT07763158

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether genicular artery embolization (GAE), a procedure that blocks certain blood vessels in the knee, can reduce persistent pain in people with severe knee osteoarthritis who haven't found relief from conservative treatments and may not be candidates for surgery. Participants are randomly assigned to either GAE or continued conservative care, and their pain and function are measured before treatment and at 6 weeks, 3 months, and 6 months after. The goal is to see if GAE can provide a meaningful reduction in pain and improvement in knee function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
genicular artery embolization, a procedure that blocks certain blood vessels in the knee to reduce pain
What this could lead to
If it works, this could offer a new pain-relief option for people with severe knee osteoarthritis who can't undergo surgery.
What could go wrong
This is a small, early-stage trial, and the procedure may not relieve pain for everyone. Risks include complications from the embolization itself, such as bleeding or tissue damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King Abdullah International Medical Research Center

    RECRUITING

    Jeddah, Mecca Region, 22490, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.